DLA Piper partners Kristi Kung and Greg Bodulovic discuss the rise of telehealth amid the COVID-19 pandemic, as well as advancements in technology aiming to address disparate access to healthcare globally.
At the Intersection of Science and Law
13 clip(s)
Life sciences companies and the risks posed by the mifepristone litigation
Trade secrets protection in the life sciences sector
Cross-border considerations for privacy in clinical trials